Fu-Han Gong

Dr. Fu-Han Gong

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 June 2018 in Journal of the American Heart Association
Verified
Journal Article
Open access
PDF file
HZHong Zhi
Hong Zhi
FGFu-Han Gong
Fu-Han Gong
WCWenlin Cheng
Wenlin Cheng
KZKongbo Zhu
Kongbo Zhu
LCLong Chen
Long Chen
HLHongliang Li
Hongliang Li
Background: Tollip, a well‐established endogenous modulator of Toll‐like receptor signaling, is involved in cardiovascular diseases. The aim of this study was to investigate the role of Tollip in neointima formation and its associated mechanisms. Methods and Results: In this study, transient increases in Tollip expression were observed in platelet‐derived growth factor‐ BB –treated vascular smooth muscle cells and following vascular injury in mice. We then applied loss‐of‐function and gain‐of‐function approaches to elucidate the effects of Tollip on neointima formation. While exaggerated neointima formation was observed in Tollip‐deficient murine neointima formation models, Tollip overexpression alleviated vascular injury–induced neointima formation by preventing vascular smooth muscle cell proliferation, dedifferentiation, and migration. Mechanistically, we demonstrated that Tollip overexpression may exert a protective role in the vasculature by suppressing Akt‐dependent signaling, which was further confirmed in rescue experiments using the Akt‐specific inhibitor ( AKTI ). Conclusions: Our findings indicate that Tollip protects against neointima formation by negatively regulating vascular smooth muscle cell proliferation, dedifferentiation, and migration in an Akt‐dependent manner. Upregulation of Tollip may be a promising strategy for treating vascular remodeling–related diseases.

1 January 2019 in Open Medicine
Verified
Journal Article
Open access
PDF file
FGFu-Han Gong
Fu-Han Gong
XXXiao-Qiang Xiao
Xiao-Qiang Xiao
XZXue-Ping Zhang
Xue-Ping Zhang
LLLi Long
Li Long
SHSheng Huang
Sheng Huang
YYYong-Sheng Yang
Yong-Sheng Yang
Atherosclerosis and chemokines are strongly related, but the role of the chemokine CXCL17 in atherogenesis is still poorly understood. We aim to investigate the serum CXCL17 levels in different stages of patients with coronary heart disease and explore whether these differences contribute to atherosclerosis. In the current prospective study, we enrolled 48 patients with unstable angina (UA), 51 patients with stable angina (SA) and 41 patients for the control group (CG). All subjects were diagnosed by coronary angiography and Gensini score was used to evaluate the severity of coronary artery disease. The CXCL17 levels were determined using ELISA, while lipid metabolism indicators and high sensitivity C-reactive protein (hs-CRP) were detected by automatic biochemical analyzer. We observed that the unstable angina group had higher CXCL17 levels compared with the stable angina and the control group. The logistic regression analysis showed that CXCL17 was an independent risk factor for unstable angina. Our results showed that CXCL17 was also statistically correlated with hs-CRP, while it was irrelevant with Gensini score. CXCL17 levels were associated with activity of inflammatory response and the instability of atherosclerotic plaques. These results suggest that CXCL17 elevation may be a potential new biomarker of unstable angina.

4 June 2025 in Atherosclerosis
Verified
Journal Article
Closed access
SZShu-Min Zhang
Shu-Min Zhang
HLHanshen Luo
Hanshen Luo
ZLZuozhi Li
Zuozhi Li
MDMingzhao Du
Mingzhao Du
JCJingjie Chen
Jingjie Chen
JYJianye Yang
Jianye Yang

31 January 2022 in American Journal of Hypertension
Verified
Journal Article
Closed access
PDF file
LZLan Zhang
Lan Zhang
QHQian-Wei Huang
Qian-Wei Huang
YPYan-Fen Pu
Yan-Fen Pu
XXXiao-Qiang Xiao
Xiao-Qiang Xiao
BSBian-Jing Song
Bian-Jing Song
FGFu-Han Gong
Fu-Han Gong
Background: RIP2 is an adaptor protein contributing to the activation of nuclear factor-κB induced by TNF receptor-associated factor (TRAF) and nucleotide oligomerization domain (NOD)-dependent signaling implicated in innate and adaptive immune response. Beyond regulation of immunity, we aimed to elucidate the role of RIP2 in vascular smooth muscle cell (VSMC) phenotypic modulation. Methods and results: In the current study, we observed that RIP2 showed an increased expression in VSMCs with PDGF-BB stimulation in a dose-dependent manner. Knockdown of RIP2 expression mediated by adenovirus dramatically accelerated the expression of VSMC-specific differentiation genes induced by PDGF-BB. Silencing of RIP2 inhibited proliferative and migratory ability of VSMCs. Additionally, we demonstrated that RIP2 knockdown can promoted myocardin expression. Furthermore, RIP2 inhibition also can attenuate the formation of intimal hyperplasia. Conclusions: These findings suggested that RIP2 played an important role in regulation of VSMCs differentiation, migration, and proliferation that may due to affect myocardin expression. Our results indicated that RIP2 may be a novel therapeutic target for intimal hyperplasia.

1 December 2023 in Canadian Journal of Physiology and Pharmacology
Verified
Journal Article
Closed access
LZLan Zhang
Lan Zhang
QHQian-Wei Huang
Qian-Wei Huang
YPYan-Fen Pu
Yan-Fen Pu
XXXiao-Qiang Xiao
Xiao-Qiang Xiao
BSBian-Jing Song
Bian-Jing Song
FGFu-Han Gong
Fu-Han Gong
Vascular smooth muscle cells (VSMCs) phenotypic switching is identified as enhanced dedifferentiation, proliferation, and migration ability of VSMCs, in which microRNAs have been identified as important regulators of the process. The present study is aimed to explore the pathophysiological effect of miR-122 on VSMC phenotypic modulation. Here, the result showed that the decreased miR-122 expression was found in VSMCs subjected to platelet-derived growth factor-BB (PDGF-BB) treatment. Next, we investigated the response of miR-122 knockdown in VSMCs with PDGF-BB stimulation. MiR-122 silencing showed increased proliferation and migration capability, whereas attenuated the differentiation markers expression. The above results were reversed by miR-122 overexpression. Finally, we further demonstrated that FOXO3 was an important target for miR-122. Collectively, we demonstrated that miR-122 silencing promoted VSMC phenotypic modulation partially through upregulated FOXO3 expression that indicated miR-122 may be a novel therapeutic target for neointimal formation.

17 May 2026 in European Journal of Pharmacology
Verified
Journal Article
Closed access
XWXuesheng Wang
Xuesheng Wang
JCJingjie Chen
Jingjie Chen
BHBo Huo
Bo Huo
WLWenxin Lin
Wenxin Lin
DJDing-Sheng Jiang
Ding-Sheng Jiang
FGFu-Han Gong
Fu-Han Gong